Prevalence and associated risk factors of Staphylococcus aureus nasal colonization among a cohort of immunocompromised individuals in Lagos, Nigeria Authors: Bimpe O Ogunleye, Oyewumi O Oshamika, Sharon O Akinpelu, Ayodeji S Ajayi, Paul A Akinduti, Kolawole S Oyedeji, Olalekan M Odeniyi, Olayemi O Akinnola Published: 2025 ABSTRACT AbstractBackgroundImmunocompromised individuals are highly vulnerable to Staphylococcus aureus (S. aureus) infections, leading to increased morbidity and mortality. This study aimed to assess the prevalence, virulence, and risk factors associated with S. aureus nasal carriage among immunocompromised individuals in Lagos, Nigeria.MethodsA total of 350 participants were enrolled, including 150 HIV/AIDS cases, 50 HIV/TB co-infections, 100 diabetes cases, and 50 controls. Nasal swabs were collected and cultured on Mannitol salt agar for the isolation of Staphylococcus aureus. Presumptive isolates were confirmed using Gram staining, catalase, and coagulase tests. Antimicrobial susceptibility was determined using the Kirby-Bauer disk diffusion method in accordance with CLSI guidelines. Molecular detection of resistance and virulence genes was performed using PCR targeting the mecA gene (methicillin resistance) and pvl (Panton-Valentine leukocidin). A structured questionnaire capturing clinical history and hygiene practices was used to evaluate risk factors for S. aureus carriage.ResultsThe overall prevalence of S. aureus was 14.6% (51/350), S. aureus was isolated in 28% (14/50) of controls, 16.7% (25/150) of HIV/AIDS patients, 14% (7/50) of HIV/TB cases and 5% (5/100) of diabetes cases. Susceptibility to erythromycin was 80.4%, gentamycin, ciprofloxacin and Sulfamethoxazole-Trimethoprim (64.7%) among all S. aureus isolated. Methicillin-resistant S. aureus (MRSA) was detected in 78.4% (40/51) of isolates, predominantly among HIV/AIDS patients (52.5%). pvl genes were identified in 11.8% (6/51) of isolates. S. aureus carriage was significantly associated with recent antibiotic use (p = 0.003) and contact with animals (p = 0.018).ConclusionThis study demonstrates a high prevalence of S. aureus among controls compared to immunocompromised individuals. These results highlight the need for further studies to elucidate the relationship between host factors and S. aureus colonization. This could inform targeted strategies for infection prevention and control.Clinical trial numberNot applicable.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12879-025-12416-x.Keywords: Staphylococcus aureus, Colonization, Nigeria Background Staphylococcus aureus is a facultative anaerobe that lives on the skin and the mucosal surface of its human host [1]. Osteomyelitis, endocarditis, pneumonia and a wide range of community and hospital-associated infections are caused by this opportunistic pathogen [2, 3]. S. aureus can colonize multiple sites in the human body. However, the nose (anterior nares) is the habitual ecological niche of this bacterium [4]. A prior study demonstrated that S. aureus strains isolated from nasal samples were genetically identical to those found in blood cultures, highlighting the connection between nasal carriage and infection. Extended nasal colonization by S. aureus could raise the risk of developing infections later on. Additionally, healthy carriers have the potential to spread the bacteria to other individuals within the community or to those with weakened immune systems [5, 6]. Staphylococcal infections have been a significant clinical and epidemiological issue in Nigerian hospitals. In the late 1980s, methicillin-resistant Staphylococcus aureus (MRSA) was first identified [7]. S. aureus nasal colonisation rates of as high as 61.8% have been reported in Nigeria [8, 9]. MRSA-associated colonization of immunocompromised patients may result in invasive infections with potential adverse outcomes because of the pathogen’s virulence factors [10]. Human immunodeficiency virus (HIV) and diabetes are considered risk factors for MRSA colonisation due to frequent oral antibiotic intake, high rates of hospitalization, low CD4+ count etc [11]. In sub-Saharan Africa, hospitalized individuals with tuberculosis (TB) and HIV have been found to have a high incidence of S. aureus [12]. Immunocompromised HIV/TB-infected/ diabetes patients are at higher risk for various opportunistic infections, caused by S. aureus and MRSA [13, 14]. It is widely known that S. aureus infections are a significant cause of HIV-positive patients’ morbidity and mortality [15]. The most prevalent MRSA infection is skin and soft tissue infections and PVL toxin is linked to this necrotizing infection [16]. The presence of S. aureus in the anterior nares poses a significant risk for staphylococcal infection in comparison to individuals who do not carry this bacterium [9]. Although there have been studies reporting on the severity and impact of S. aureus infections, the specific factors that predispose HIV and HIV/TB patients to such infections have not been extensively researched. Hence, it is crucial to pinpoint lifestyle-related factors that may lead to S. aureus colonization, to prevent transmission and subsequent infections. The aim of the study was to determine the prevalence of S. aureus colonization in the anterior nares of people living with HIV/AIDS, HIV/Tuberculosis co-infected individuals, and diabetic patients and examine the risk factors associated with nasal colonization of S. aureus in these individuals. Methods Study population This was a case-control study carried out on patients attending AIDS preventative initiative center (APIN), Directly Observed Therapy (DOT) and diabetes clinics of the Lagos University Teaching Hospital (LUTH), Idi-Araba, Lagos, from December 2019 to March 2020. People who have been diagnosed with HIV, HIV/TB, and diabetes, and were receiving treatment at specified LUTH clinics made up the study population. Hospital workers who did not have HIV, HIV/TB or diabetes were recruited at the hospital as controls. To minimize selection bias, controls were recruited from diverse hospital departments, ensuring representation from various roles, including nurses, laboratory staff, and administrative personnel. Participants included healthcare workers, educators, administrative staff, artisans, civil servants and traders. A consecutive sampling technique was employed, whereby all eligible participants presenting to the outpatient clinic during the study period were invited to participate until the desired sample size was achieved. Ethical considerations This study was given ethical clearance by the College of Medicine, Lagos University Teaching Hospital Research Ethics Committee, Idi-Araba, Lagos State (Approval number: CMUL/HREC/11/19/663). Written informed consent was obtained from all participants. Informed consent was also obtained from the parents or guardians of all participants younger than 16 and assent was obtained from participants older than 10 years. Additionally, all the information obtained from the study subjects were coded to maintain confidentially. Inclusion and exclusion criteria Inclusion criteria were established cases of HIV, HIV/TB coinfected and diabetic patients, and willingness to sign an informed consent. The controls were recruited based on their negative diagnosis status for HIV, HIV/TB or diabetes. Exclusion criteria were unwillingness to sign the informed consent, children with diabetes, and patients with chronic illness or other co-morbidities. Controls with chronic respiratory diseases (e.g., asthma, chronic obstructive pulmonary disease) were also excluded. Data collection To obtain socio-demographic data and risk factors for S. aureus nasal colonisation, a questionnaire was administered to the study participants (Supplementary material). Information collected include age, sex, ethnicity, hygiene practices (such as cleaning of nose, washing of hands), hospitalization in the past six months, surgery history, hospitalization of household members in the past one year, contact with animals, habits (such as smoking), recent antibiotic usage, disease history, involvement in sporting activities among others. Medical history was obtained from the clinic medical records. Sample size calculation According to Olalekan et al. [17], the prevalence of S. aureus nasal carriage for previous research in Lagos State was 27%. Estimated sample size using Fisher’s Formula: Where: n = sample size z = level of confidence according to the standard normal distribution (for a level of confidence of 95%, z = 1.96, for a level of confidence of 99%, z = 2.575) p = known characteristic or prevalence about the population q = 1- p (probability of failure). d = tolerated margin of error NB: Where prevalence is 27%, p = 0.27, q = 1- 0.27 = 0.73 Hence, Based on this calculation, the minimum sample size of 250 is needed for this study. Sample collection Pre-moistened swab sticks were inserted into the patient’s nostrils and gently swirled and rotated in both anterior nares to obtain the nasal samples. The nasal swabs were labelled correctly and placed in the containers. Within an hour of collection, the collected samples were transported to the microbiology laboratory in an ice pack for further analysis. Isolation and biochemical identification of isolates All swabs were inoculated on Mannitol salt agar (MSA) aseptically, and aerobically incubated for 24 h at 37 °C. Golden yellow distinct colonies were sub-cultured on Mannitol salt agar (MSA) and incubated aerobically at 37 °C for 24 h. Golden yellow colonies were presumptively identified as S. aureus based on colony morphology, Gram staining, and biochemical tests such as catalase, coagulase, and sugar fermentation. The isolates were then sub-cultured on blood agar to check for the characteristic beta haemolysis displayed by S. aureus [18]. The isolates were further stored on agar slants at 4℃. Antibiotic susceptibility testing The susceptibility profile of the S. aureus isolates to different antimicrobial agents was determined using the Kirby-Bauer disc diffusion method on Mueller-Hinton agar [19]. The antibiotics tested were Gentamicin (30 µg), Erythromycin (15 µg), Ciprofloxacin (5 µg), Ampicillin (10 µg), Penicillin (10 µg), Tetracycline (30 µg), Oxacillin (1 µg), Trimethoprim-Sulfamethoxazole (5 µg) (Oxoid, UK). The control strain used for quality control was Staphylococcus aureus ATCC 25,923. The results were interpreted following the Clinical and Laboratory Standard Institute (CLSI, 2019) guidelines. Molecular detection of mecA and pvl genes The complete genomic DNA was extracted from S. aureus isolates using a modified cholorophenol method. The swabs were placed in 1.0 ml of phosphate-buffered saline (PBS), gently mixed, and then centrifuged at 1000 rpm for 5 min. To the resulting suspension, 100 µL of a solution containing 250 mmol/L EDTA and 750 mmol/L NaCl, 100 µL of 100 g/L sodium dodecyl sulfate, and 20 µL of proteinase K (final concentration 20 mg/mL) were added. The samples were incubated at 56 °C for 2 h. Proteins were then precipitated by adding 200 µL of saturated 6 M NaCl solution (final concentration 0.86 mol/L). DNA extraction was performed using a 1:1 phenol-chloroform mixture at room temperature. After incubating for 5 min, the mixture was centrifuged at 14,000 g for 15 min. The clear supernatant was transferred to a new tube, and DNA was precipitated by adding an equal volume of absolute ethanol, followed by overnight incubation at -20 °C. The DNA was then centrifuged again at 14,000 g for 15 min, washed with 70% ethanol, and finally dissolved in 50 µL of water. All S. aureus strains were tested to identify MRSA. Those S. aureus strains that were positive for the mecA gene were identified as MRSA. The presence of mecA which codes for methicillin resistance in S. aureus isolates was determined using primers (F-AAAATCGATGGTAAAGGTTGGC; R-AGTTCTGCAGTACCGGATTTGC with a product size of 533 bp as described by Ayepola et al. [10]. The Panton-Valentine leucocidin (pvl) gene (lukF-PV) was identified using these primers (F-ATCATTAGGTAAAATGTCTGGACATGATCCA, R-GCATCAAGTGTATTGGATAGCAAAAGC) with a product size of 433 bp as described by Ayepola et al. [20]. The amplified products were visualized using 1% agarose gels under UV light. Statistical analysis To determine the risk factors associated with Staphylococcus aureus nasal carriage among people living with HIV, HIV / TB co-infected individuals, and diabetic patients, statistical analysis was performed using Chi-square from the Statistical Package for Social Sciences (SPSS) version 20. Categorical variables were compared by the chi-square test or odds ratios (OR), 95% confidence intervals (CI), and p values were calculated. A p-value of ≤ 0.05 was considered statistically significant. Results Characteristics of study population A total of 350 participants were enrolled in this study. Of the 350 samples, 150 were collected from people living with HIV/AIDS, 50 from HIV/TB co-infected individuals, 100 from diabetic patients, and 50 control participants. Of the 350 participants, fifty-nine were male (16.9%) and 291 were female (83.1%). Most participants were aged 57-above (25.4%) and most of the participants were married (219, 62.6%). Regarding their level of education, 15 (4.3%) of the participants were uneducated, 71 (20.3%) had primary school education, 131 (37.4%) had secondary school education, and 124 (35.4%) had tertiary education. Detailed demographic data are shown in Table 1. Table 1Demographics of study participants with Staphylococcus aureus colonisation attending Lagos University Teaching Hospital (LUTH) from December 2019 to March 2020S. aureus colonisationP-valuePresent N (%)Absent N (%)Total N (%)Age Group8–143 (5.9%)3 (1.0%)6 (1.7%)0.00015–213 (5.9%)1 (0.3%)4 (1.1%)22–288 (15.7%)26 (8.7%)34 (9.7%)29–3512 (23.5%)36 (12.0%)48 (13.7%)36–4210 (19.6%)67 (22.4%)77 (22.0%)43–494 (7.8%)27 (9.0%)31 (8.9%)50–566 (11.8%)55 (18.4%)61 (17.4%)57&above5 (9.8%)84 (28.1%)89 (25.4%)SexMale6 (11.8%)53 (17.7%)59 (16.9%)0.293Female45 (88.2%)246 (82.3%)291 (83.1%)Marital StatusSingle17 (33.3%)52 (17.4%)69 (19.7%)0.035Married28 (54.9%)191 (63.9%)219 (62.6%)Widowed/Divorced6 (11.8%)56 (17.7%)62 (17.7%)Educational StatusTertiary18 (35.3%)106 (35.5%)124 (35.4%)0.251Secondary16 (49.0%)115 (38.5%)131 (37.4%)Primary7 (13.7%)64 (21.4%)71 (20.8%)None1 (10.9%)14 (89.1%)15 (4.3%)OccupationCivil servant2 (3.9%)41 (13.7%)43 (12.3%)0.001Trader15 (29.4%)148 (49.5%)163 (46.6%)Others34 (66.6%)110 (36.8%)144 (41.1%) Demographics of study participants with Staphylococcus aureus colonisation attending Lagos University Teaching Hospital (LUTH) from December 2019 to March 2020 Widowed/ Divorced Prevalence of Staphylococcus aureus among study participants Staphylococcus aureus was isolated from 51 (14.6%) of the 350 samples collected. Of the 150 samples collected from people living with HIV/AIDS, 25 (16.7%) S. aureus were isolated, 7 (14%) from 50 HIV/TB co-infected individuals, 5 (5%) from 100 diabetic patients, and 14 (28%) from 50 control participants. The distribution of Staphylococcus aureus in study participants are shown in Tables 2 and 3. Table 2Prevalence of Staphylococcus aureus among immunocompromised groupsGroupS. aureus present N (%)S. aureus absent N (%)Total number of swabs collectedOR (95% CI)P -value (disease vs. control)HIV25 (16.7%)125 (83.3%)1500.51 (0.24–1.09)0.080HIV/TB7 (14.0%)43 (86.0%)500.42 (0.15–1.15)0.086Diabetes5 (5.0%)95 (95.0%)1000.14 (0.05–0.40)0.000Control14 (28.0%)36 (72.0%)50-Total51 (14.6%)299 (85.4%)350- Prevalence of Staphylococcus aureus among immunocompromised groups Table 3Gender distribution of S. aureus colonisation among study groupsGroupGenderS. aureus present N (%)S. aureus absent N (%)HIVMale3 (12.0%)7 (5.6%)Female22 (88.0%)118 (94.4%)HIV/TBMale0 (0.0%)23 (53.5%)Female7 (100.0%)20 (46.5%)DiabetesMale2 (40.0%)22 (23.1%)Female3 (60.0%)73 (76.9%)ControlMale1 (7.1%)1 (2.8%)Female13 (92.9%)35 (97.2%) Gender distribution of S. aureus colonisation among study groups Risk factors associated with nasal carriage of S. aureus Recent use of antibiotics (p = 0.003), regular contacts with animals (p = 0.018) and household member contact with animals (p = 0.009) as well as regular hand washing (p = 0.008) were significantly associated with nasal carriage of S. aureus. There was no significant relationship between hospitalization in the last six months, history of surgical procedures, participation in sports among others with S. aureus nasal carriage (Table 4). Table 4Risk factors associated with nasal carriage of S. aureus nasal colonization in immunocompromised individuals in Lagos, NigeriaRisk FactorsS. aureus colonisationPresent N (%)Absent N (%)P-valueRecent use of AntibioticsNo29 (56.9%)126 (42.1%)0.003Yes22 (43.1%)173 (57.9%)Use of inhalerNo47 (92.4%)288 (96.3%)0.398Yes4 (7.8%)11 (3.7%)Nose pickingDaily18 (35.3%)114 (38.1%)0.267Weekly3 (5.9%)24 (8.0%)Twice a week5 (9.8%)8 (2.7%)Frequently11 (21.6%)63 (21.1%)Others14 (27.5%)90 (30.1%)Nose bleedingRegularly1 (2.0%)7 (2.3%)0.371Seldom3 (5.9%)7 (2.3%)Never47 (95.2%)285 (95.3%)Regular hand washingHourly3 (5.9%)28 (9.4%)0.008Frequently47 (92.2%)203 (67.9%)Rarely1 (2.0%)59 (19.7%)Never1 (0.0%)9 (3.0%)Hand washing after picking noseNo10 (19.6%)112 (37.5%)0.017Yes19 (37.3%)113 (37.8%)Sometimes22 (43.1%)74 (24.7%)Regular contact with animalsNo49 (95.5%)240 (80.3%)0.018Yes2 (3.9%)59 (19.7%)Household member contact with animalsNo43 (84.3%)215 (71.9%)0.009Yes3 (5.9%)71 (23.7%)Don’t know5 (9.8%)13 (4.3%)Household member as healthcare workerNo39 (76.4%)253 (84.6%)0.352Yes12 (23.5%)46 (15.4%)Hospital admission of household memberNo41 (80.4%)230 (76.9%)0.942Yes6 (11.8%)45 (15.1%)Don’t know28 (8.0%)24 (8.0%)Hospital admission in the last six monthsNo46 (90.2%)249 (83.3%)0.230Yes5 (9.8%)50 (16.7%)Recent consumption of antibioticsNo30 (58.9%)130 (43.5%)0.119Yes21 (41.2%)169 (56.5%)Recent surgeryNo19 (37.3%)185 (61.8%)0.907Yes18 (35.3%)114 (38.1%)Participation in sportsNo40 (80.4%)262 (87.6%)0.087Yes10 (19.6%)37 (12.4%) Risk factors associated with nasal carriage of S. aureus nasal colonization in immunocompromised individuals in Lagos, Nigeria Antimicrobial susceptibility profile of bacterial isolates The antimicrobial susceptibility of the 51 S. aureus isolates was 5/51 (9.8%) for Penicillin G, 13/51 (25.5%) for oxacillin, 33/51 (64.7%) for ciprofloxacin, 41/51 (80.4%) for erythromycin, 33/51 (64.7%) for gentamycin, 33/51 (64.7%) for Sulfamethoxazole-Trimethoprim, 16/51 (31.4%) for tetracycline and 0/51 (0%) for ampicillin (Fig. 1). Table 5 shows the antibiotic susceptibility pattern of S. aureus among the immunocompromised groups. Antibiotic susceptibility pattern of Staphylococcus aureus isolates. P: Penicillin G; OX: Oxacillin, CIP: Ciprofloxacin; E: Erythromycin; CN: Gentamicin; SXT: Sulfamethoxazole-Trimethoprim; TE: Tetracycline; AMP: Ampicillin Table 5Antibiotic susceptibility pattern of S. aureus among the immunocompromised groupsAntibioticsHIV (%)HIV/TB (%)Diabetes (%)Penicillin12.0%14.3%20.0%Tetracycline32.0%71.4%40.0%Oxacillin80.0%57.1%40.0%Ciprofloxacin72.0%57.1%60.0%Gentamicin68.0%100.0%100.0%Trimethoprim-Sulfamethoxazole52.0%57.1%80.0%Erythromycin64.0%57.1%0.0%Ampicillin0.0%0.0%0.0% Antibiotic susceptibility pattern of S. aureus among the immunocompromised groups Prevalence of MRSA colonisation and pvl gene Among the 51 S. aureus isolates, 40 (78.4%) were identified as MRSA (having the mecA gene). The MRSA colonization among the HIV patients was 84% (n = 21/25), HIV/TB % (n = 4/5) and diabetes groups were both 80% (n = 4/5) among 5 S. aureus isolates. Among healthy controls, 78.6% (11/15) S. aureus isolates were identified as MRSA. Six (6/51; 11.8%) S. aureus isolates were positive for the pvl (lukf-PV) gene. pvl gene was detected among the HIV patients (12%, n = 3/25), HIV/TB (20%, n = 1/5) and diabetics (0%, n = 0/5). pvl gene was detected in 40% (2/5) S. aureus isolates in controls. Discussion The ubiquitous presence of S. aureus has been demonstrated by the isolation of S. aureus in the nares of the groups of immunocompromised individuals that is, HIV, HIV/TB co-infected individuals, diabetic patients, as well as the control subjects. This study’s outcome showed an overall prevalence of 14.6% Staphylococcus aureus colonization in the nares of the 350 participants who volunteered in the study. In other studies, conducted in Nigeria, nasal colonisation rates of 61.8%, 32.0% and 23.0% have been reported respectively [8, 21, 22]. The low frequency of S. aureus detection could be attributed to the absence of selective enrichment prior to culturing on agar plates. In this study, recent use of antibiotics, regular contacts with animals and household member contact with animals were the most predisposing factors for S. aureus nasal carriage. In contrast to our results, Olalekan et al. reported a higher prevalence of S. aureus nasal colonization in HIV patients (27.0%) than our study (16.7%) [17]. Similar results were reported by Muhaba et al. [23], Kotpal et al. [24] and Abiye et al. [25] where they obtained 61.7%, 44.0% and 37.8% respectively. Some authors have reported the risk factors associated with colonization/infection by S. aureus in HIV patients as use of antimicrobials, previous hospitalization and low CD4 + T lymphocyte counts (< 200 cells/µl) [13]. In our study, the nasal colonization rate of HIV/TB co-infected individuals was found to be 14%. This is significantly higher than the colonization rate obtained in Ghana (4.8%) [26]. Recent / frequent exposure to antibiotics leading to a greater likelihood of becoming colonized with resistant strains, as well as regular contact with animals and contact with animals by household members, could be the reason for this high prevalence rate. Some authors have raised certain arguments that this increased susceptibility to S. aureus colonization could be HIV-specific because of the compromised immunity [27]. The higher S. aureus carriage among control participants in this study may partly reflect occupational exposure, as controls were hospital workers who could have increased contact with potential sources of S. aureus transmission despite being otherwise healthy. The prevalence of S. aureus (5.0%, 5/100) nasal colonization among the diabetic patients in this study was lower compared to other studies among diabetic population in Turkey (41.9%) [28], long term haemodialysis type 2 diabetic patients in Saudi Arabia (72.4%) [29], hospitalized diabetic patients in India (56.6%) [30], diabetic patients in Australia (39.1%) [31], as well community based diabetes population (8.7%) in China [12]. One explanation could be that these diabetic patients had a distinct nasal microbiome. The variance observed in prevalence studies may be explained by the competition between various bacteria for the same location caused by their presence in these individuals’ microbiota. The antibiotic susceptibility tests showed Ampicillin and Penicillin G to be the least effective agents with 0% and 9.8% susceptibility respectively. These results are consistent with earlier studies investigating S. aureus in Nigeria [32, 33]. The widespread indiscriminate use and abuse of antibiotics could be responsible for low sensitivity of isolates from this study to frequently used antibiotics. Penicillin has been reported as a highly misused antibiotic in Nigerian communities because it is cheap and easily obtainable through lenient medication regulations [34]. This suggests that these antibiotics can no longer be effectively used as empirical treatment for S. aureus infections particularly in the study area. The most effective antimicrobials against S. aureus on HIV patients was oxacillin while in HIV/TB and diabetes group was gentamycin. Overall, the most effective antimicrobials against S. aureus isolates in this study were erythromycin, ciprofloxacin, gentamycin and sulfamethoxazole-Trimethoprim. This is similar to antibiotic susceptibility profiles reported by other researchers in Nigeria [35–37]. Moro [33] also reported high susceptibility of S. aureus to Erythromycin (90.3%) and Gentamycin (87.5%). This reveals the likely antibiotics of choice for the treatment of S. aureus infection in the area under study. A total of 40 isolates (78.4%) were confirmed as MRSA based on the detection of the mecA gene. This is significantly higher than Ayepola et al. [10] Ayepola et al. [34] and Shittu et al. [36] where mecA gene was detected in 16.2% and 2.4% of Staphylococcus aureus isolates respectively. MRSA colonization and infections have been increasingly reported in HIV patients. The reason for this high prevalence is not clear, but it has been associated with antibiotic use, frequent contact with healthcare workers, and geographical locations [12, 38, 39]. Skin and soft tissue infections (SSTI) have been linked to the virulence mechanism by PVL. Since its discovery in 1932, the toxin has been linked to abscesses and severe, necrotizing pneumonia in either MRSA or methicillin-sensitive isolates [40]. Among S. aureus isolates obtained from this study, 6 (11.8%) possess the Panton-Valentine leucocidin (pvl) gene (lukF-PV). However, a higher prevalence of 24%, 56%, 40%, 20% were reported by O’Malley et al. [9], Ayepola et al. [10], Shittu et al. [36], and Mbogori et al. [41] respectively. The prevalence of PVL toxin genes in a study by Orji et al. was 10.7% [42]. It is important to routinely screen clinical isolates for the presence of the pvl gene in S. aureus because of the serious clinical consequences [40]. The potential for the emergence of a multidrug-resistant PVL-positive MRSA clone is highlighted by the co-occurrence of PVL-positive S. aureus and multidrug-resistant MRSA. Soon, the spread of PVL-positive MRSA could pose a significant obstacle to disease management and infection control. These strains are on the rise in Africa, which causes concern about the potential for spread of highly virulent strains. Limitations This study only evaluated the presence of genes for two virulence factors genes (mecA, pvl) in Staphylococcus aureus. A further limitation of this study was the use of oxacillin disk diffusion for the phenotypic detection of methicillin-resistant Staphylococcus aureus (MRSA). While oxacillin has been traditionally used, the Clinical and Laboratory Standards Institute (CLSI) now recommends cefoxitin disk diffusion as a more dependable indicator due to its higher sensitivity and clearer zone edges, which better identify mecA-mediated resistance. Future research should adopt cefoxitin disk testing to enhance the accuracy of MRSA detection. Additionally, vancomycin was not included in the susceptibility testing panel. Incorporating vancomycin along with other key agents like linezolid or clindamycin would improve the clinical relevance of antimicrobial resistance assessments in subsequent studies. Conclusion Understanding the prevalence of nasal carriage among people living with HIV/AIDS, HIV/TB co-infected individuals and diabetic patients is important in the epidemiological study of nasal carriage among immunocompromised individuals. The high resistance of the isolates to antibiotics, with the presence of PVL, could threaten the treatment and outcomes of infections caused by S. aureus in these immunocompromised populations. There is a need for continuous surveillance of S. aureus in Africa, antibiotic stewardship and infection prevention and control to stop the spread of epidemic strains and promotion of better hygiene practices. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Acknowledgements The authors acknowledge Covenant University Centre for Research, Innovation and Discovery (CUCRID) for their support towards this study. Abbreviations Acquired Immunodeficiency Syndrome AIDS Preventative Initiative Center Clinical & Laboratory Standards Institute Directly Observed Therapy Ethylenediaminetetraacetic acid Human Immunodeficiency virus Lagos University Teaching Hospital Methicillin-resistant Staphylococcus aureus Mannitol salt agar Panton-Valentine leukocidin Tuberculosis Author contributions BOO: conceptualization, writing—original draft, methodology, validation, investigation, formal analysis. OOO: writing—original draft, visualization, validation, methodology, investigation, formal analysis, writing—review & editing. SOA: writing—original draft, visualization, methodology, validation, investigation, formal analysis, data curation, writing—review & editing. ASA: writing—original draft, visualization, validation, methodology, investigation, formal analysis, writing—review & editing. KSO & OMO: conceptualization, methodology, validation, writing—review & editing. OOA: conceptualization, writing—original draft, visualization, methodology, validation, investigation, formal analysis, writing—review & editing. Funding This study received no external funding, Data availability The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate This study was given ethical clearance by the College of Medicine, Lagos University Teaching Hospital Research Ethics Committee, Idi-Araba, Lagos State (Approval number: CMUL/HREC/11/19/663) and all participants signed written informed consent. The entire study procedures were in accordance with the Declaration of Helsinki. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1 Data Availability Statement The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.